Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 33.3%, free cash flow grew 12.7% and total debt fell 12.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

16.42 0.33 +2.05%
Market cap
$10.9B
P/E
0.0×
Fwd P/E
25.5×
Dividend yield
—
F-score
4/9
Altman Z
1.55
Beneish M
−2.91
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Piotroski F-Score
4 6 5 6 5 7 — — — —
P/E ratio
0.00 20.07 47.40 20.55 49.00 312.78 0.00 0.00 0.00 0.00
P/S ratio
1.19 2.11 2.21 1.83 3.37 2.54 1.21 0.00 0.00 0.00
Altman Z-Score
1.55 2.52 2.16 2.00 2.44 2.33 1.49 — — —
Altman Z″-Score (non-manufacturers)
1.86 2.29 1.91 1.93 1.52 1.49 1.30 0.49 — 1.08
P/FCF ratio
15.76 20.69 21.24 19.40 29.54 18.69 24.08 8.54 8.54 8.54
P/Operating CF
51.08 82.63 61.09 67.02 82.67 53.02 83.70 25.67 25.67 25.67
Beneish M-Score
(2.91) (2.58) (2.70) (2.53) (2.47) (2.76) (2.52) — — —
P/B ratio
1.40 2.40 2.93 2.84 7.79 9.71 4.99 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
1.74 2.67 2.96 2.62 4.28 3.26 2.02 0.00 0.00 0.00
EV/EBITDA
65.97 12.06 18.57 12.69 23.11 18.51 12.41 0.00 0.00 0.00
EV/Operating CF
18.24 21.54 23.73 23.35 33.14 22.40 34.50 31.45 31.45 31.45
EV/FCF
22.99 26.18 28.53 27.73 37.51 23.99 40.38 38.45 38.45 38.45
Quick Ratio
1.04 0.65 0.95 0.96 1.05 1.13 1.09 1.02 0.96 1.11
Current Ratio
1.78 1.07 1.61 1.60 1.71 1.80 1.88 1.73 1.66 2.15
Net Debt/EBITDA
20.76 2.53 4.74 3.81 4.91 4.09 5.01 7.84 (69.68) 12.58
Debt/Assets
33.46% 33.48% 42.68% 46.70% 50.54% 49.40% 52.35% 69.86% 0.00% 114.08%
Debt/Equity
0.71 0.68 1.05 1.29 1.67 1.83 2.08 (2.27) 0.00 (3.46)
Asset Turnover
0.55 0.54 0.53 0.55 0.62 0.65 0.61 1.06 2.20 0.12
Operating CF/Net income
(1.18) 1.18 2.71 1.27 1.88 17.88 (1.06) (0.56) 1.49 (1.74)
Capex/Depreciation
(0.31) (0.36) (0.35) (0.32) (0.28) (0.15) (0.12) (0.08) (0.23) 0.00
Interest Coverage
(1.45) 4.96 2.45 4.25 4.47 2.30 1.25 0.79 (1.05) 0.69
ROE
(9.20%) 12.69% 6.35% 16.46% 20.89% 3.32% 42.07% 12.57% 7.53% 2.80%
ROA
(4.44%) 5.67% 2.43% 4.84% 4.27% 0.53% (3.40%) (6.45%) (19.84%) (0.73%)
ROIC
(1.68%) 6.95% 4.13% 6.56% 5.57% 6.07% 4.67% 7.01% (1.90%) 0.00%
Return on Tangible Assets
(28.83%) 83.98% 19.55% 38.37% 29.33% 3.38% (22.28%) (25.42%) (8.08%) (11.67%)
Average Days of Receivables
59.86 55.66 60.26 59.20 60.39 63.56 59.75 57.96 256.03 46.48
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
24.35% 24.19% 21.62% 19.60% 20.72% 21.49% 22.66% 23.96% 36.05% 40.96%
Intangible Assets out of Total Assets
0.69 0.73 0.73 0.73 0.75 0.70 0.72 0.74 0.00 0.55
Share Based Compensation of Revenue
0.71% 0.69% 0.58% 0.61% 0.69% 0.69% 1.12% 0.31% 3.86% 0.00%
Graham Net Nets
(0.48) (0.28) (0.35) (0.43) (0.29) (0.31) (0.73) 0.99 0.99 0.99
Graham Number
0.00 14.39 9.16 13.15 10.23 2.42 0.00 0.00 0.00 0.00
Earnings Yield
(6.81%) 4.98% 2.11% 4.87% 2.04% 0.32% (5.05%) (10.55%) (10.55%) (10.55%)
Free Cash Flow Yield
6.35% 4.83% 4.71% 5.15% 3.39% 5.35% 4.15% 11.71% 11.71% 11.71%
Revenue per Share
9.63 9.98 10.31 11.54 12.51 11.09 15.06 44.19 8.26 1.29
Operating CF per Share
0.92 1.24 1.29 1.30 1.61 1.61 0.88 1.51 (1.11) 0.14
Capex per Share
(0.19) (0.22) (0.22) (0.20) (0.19) (0.11) (0.13) (0.28) (0.17) 0.00
Free Cash Flow per Share
0.73 1.02 1.07 1.09 1.43 1.51 0.75 1.23 (1.28) 0.14
Cash per Share
0.54 0.39 0.39 0.57 0.51 0.50 0.47 1.39 1.22 0.12
Shareholders Equity per Share
8.18 8.77 7.77 7.46 7.11 4.64 6.14 (23.00) 0.00 (0.70)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
8.18 8.77 7.77 7.46 7.11 4.64 6.14 (23.00) 0.00 (0.70)
Free Cash Flow
495.00 692.00 723.60 710.20 842.50 868.20 302.40 162.80 (192.70) 72.90
Working Capital
1,072.30 139.10 904.60 999.10 1,026.40 988.20 947.00 803.40 730.00 156.00
Capital Expenditures
(128.80) (148.80) (146.40) (133.40) (111.10) (61.60) (51.60) (37.70) (25.20) (29.90)
Net Current Asset Value
(3,778.50) (4,011.20) (5,335.20) (5,951.00) (7,223.00) (5,001.30) (5,289.60) (11,063.70) 1,834.00 (1,354.00)
EV/EBIT
0.00 16.70 29.64 17.43 32.51 29.47 22.13 0.00 0.00 0.00
Capex to Sales
0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.02 0.00
Price to Operating Income
0.00 13.20 22.07 12.19 25.60 22.95 13.20 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.55 0.59 0.56 0.58 0.56 0.76 0.78 0.75 0.17 0.30
Cash ROIC
5.01% 6.74% 6.55% 6.17% 7.31% 11.05% 3.89% 4.01% (2.64%) 7.41%
Accounts Receivable Turnover
6.21 6.21 5.88 6.16 6.33 6.08 6.29 6.49 2.59 1.44
Accounts Payable Turnover
6.28 6.99 6.65 6.49 6.81 6.96 7.37 7.36 2.76 1.26
Inventory Turnover
5.70 5.78 5.29 5.50 6.06 5.95 5.96 5.92 1.99 0.91
Average Days of Payables
61.35 53.71 49.63 56.37 56.44 57.45 49.63 50.30 242.86 47.10
Days of Inventory on Hand
67.68 59.28 65.66 67.91 65.18 62.59 63.01 60.56 311.41 119.70
Average Receivables
1,054.55 1,092.35 1,184.30 1,220.25 1,167.70 1,051.05 960.00 903.10 481.50 481.50
Average Payables
702.25 644.35 692.05 756.65 717.00 619.55 558.80 549.70 295.00 295.00
Average Inventory
774.85 779.80 870.80 892.75 805.80 725.40 691.15 683.05 408.50 408.50
Average Assets
11,954.60 12,543.60 13,218.50 13,680.75 11,901.85 9,839.90 9,842.45 5,523.80 568.00 5,791.50
Average Common Equity
5,760.85 5,604.65 5,054.00 4,024.35 2,431.95 1,564.55 (796.60) (2,835.85) (1,497.50) (1,497.50)

Fold the line items

Columns are period end dates